{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:40:18Z","timestamp":1786362018611,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009164","name":"H Lee Moffitt Cancer Center and Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtct.2025.09.022","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:00:01Z","timestamp":1761008401000},"page":"78.e1-78.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5150-576X","authenticated-orcid":false,"given":"Eric","family":"Gaskill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4802-5445","authenticated-orcid":false,"given":"Omar","family":"Albanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Mahrukh Hussnain","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxing","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Belfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7750-781X","authenticated-orcid":false,"given":"Rawan","family":"Faramand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9605-6436","authenticated-orcid":false,"given":"Aleksandr","family":"Lazaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-3578","authenticated-orcid":false,"given":"Doris K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-4711","authenticated-orcid":false,"given":"Farhad","family":"Khimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-4294","authenticated-orcid":false,"given":"Asmita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-4381","authenticated-orcid":false,"given":"Hien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-0622","authenticated-orcid":false,"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelli","family":"Bejanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-4636","authenticated-orcid":false,"given":"Hany","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2025.09.022_bib0001","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.20945","article-title":"Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis","volume":"103","author":"Yanada","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.022_bib0002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.2019001982","article-title":"How I treat relapsed or refractory AML","volume":"136","author":"DeWolf","year":"2020","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jtct.2025.09.022_bib0003","first-page":"2333","article-title":"Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R","volume":"123","author":"Della Porta","year":"2014","journal-title":"Blood J Am Soc Hematol"},{"issue":"22","key":"10.1016\/j.jtct.2025.09.022_bib0004","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.022_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the US registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jtct.2025.09.022_bib0006","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.09.022_bib0007","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. 2017."},{"issue":"8","key":"10.1016\/j.jtct.2025.09.022_bib0008","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jjco\/hyaa053","article-title":"Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia","volume":"50","author":"Yu","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.022_bib0009","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbmt.2010.04.009","article-title":"Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults","volume":"16","author":"Navarro","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.022_bib0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/bmt.2014.280","article-title":"Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes","volume":"50","author":"Gleimer","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.022_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2011.01445.x","article-title":"The relationship between body mass index and outcomes in leukemic patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Hadjibabaie","year":"2012","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.022_bib0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bcmd.2013.01.010","article-title":"Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant","volume":"51","author":"Jaime-Perez","year":"2013","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.022_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bmt.2013.128","article-title":"Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis","volume":"49","author":"Nakao","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.09.022_bib0014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00277-010-1001-6","article-title":"Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies","volume":"89","author":"Nikolousis","year":"2010","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0015","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41409-018-0234-1","article-title":"Impact of body mass index at different transplantation stages on postoperative outcomes in patients with hematological malignancies: a meta-analysis","volume":"53","author":"Ren","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0016","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/ejcn.2016.225","article-title":"Effect of body mass index on overall survival of patients with allogeneic hematopoietic stem cell transplantation","volume":"71","author":"Yang","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"25","key":"10.1016\/j.jtct.2025.09.022_bib0017","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0018","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.022_bib0019","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.022_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"De Lima","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bmt.1705282","article-title":"Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Singhal","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.jtct.2025.09.022_bib0022","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.21.00471","article-title":"Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update","volume":"39","author":"Griggs","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2025.09.022_bib0023","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrclinonc.2013.108","article-title":"Chemotherapy dosing in overweight and obese patients with cancer","volume":"10","author":"Lyman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.022_bib0024","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2014.01.019","article-title":"Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee","volume":"20","author":"Bubalo","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.022_bib0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/j.1875-9114.2012.01108.x","article-title":"Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults","volume":"32","author":"Pai","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.jtct.2025.09.022_bib0026","doi-asserted-by":"crossref","first-page":"1090.e1","DOI":"10.1016\/j.jtct.2024.08.007","article-title":"Melphalan dose in combination with fludarabine affects gastrointestinal toxicity and graft-versus-host disease after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndromes","volume":"30","author":"Albanyan","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.022_bib0027","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bbmt.2013.07.008","article-title":"A randomized phase II trial of fludarabine\/melphalan 100 versus fludarabine\/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma","volume":"19","author":"Bashir","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.022_bib0028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2018.11.005","article-title":"Effect of conditioning regimen dose reduction in obese patients undergoing autologous hematopoietic cell transplantation","volume":"25","author":"Brunstein","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0029","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood.2019003662","article-title":"Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?","volume":"135","author":"Ciurea","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.022_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bcp.12906","article-title":"High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation","volume":"82","author":"Nath","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.022_bib0031","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2006.11.024","article-title":"Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.022_bib0032","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbmt.2019.02.002","article-title":"Impact of donor type and melphalan dose on allogeneic transplantation outcomes for patients with lymphoma","volume":"25","author":"Saini","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.022_bib0033","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/bmt.2014.186","article-title":"Not too little, not too much-just right! (Better ways to give high dose melphalan)","volume":"49","author":"Shaw","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.022_bib0034","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbmt.2017.11.041","article-title":"Impact of dose-adjusted melphalan in obese patients undergoing autologous stem cell transplantation","volume":"24","author":"Shultes","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.022_bib0035","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbmt.2011.05.005","article-title":"Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"17","author":"Vogl","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.jtct.2025.09.022_bib0036","first-page":"51s","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013the evidence report","volume":"6","year":"1998","journal-title":"National Institutes of Health. Obes Res"},{"key":"10.1016\/j.jtct.2025.09.022_bib0037","unstructured":"Organization, W.H. Obesity and overweight. 2024; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"issue":"6","key":"10.1016\/j.jtct.2025.09.022_bib0038","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.022_bib0039","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1016\/j.jtct.2025.09.022_bib0040","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.022_bib0041","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.09.022_bib0042","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000532","article-title":"Nutritional Status at diagnosis and pre-transplant weight loss impact outcomes of acute myeloid leukemia patients following allogeneic stem cell transplantation","volume":"5","author":"Brauer","year":"2021","journal-title":"Hemasphere"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.022_bib0043","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/bmt.2014.178","article-title":"Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT","volume":"49","author":"Fuji","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.022_bib0044","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12185-011-0980-y","article-title":"The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning","volume":"95","author":"Sucak","year":"2012","journal-title":"Int J Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.09.022_bib0045","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1182\/bloodadvances.2021004192","article-title":"Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant","volume":"5","author":"Al Malki","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2025.09.022_bib0046","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bmt.2009.66","article-title":"Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU\/MEL conditioning regimen in context with BU\/CY2","volume":"44","author":"Vokurka","year":"2009","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:12:51Z","timestamp":1768630371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725014447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666636725014447"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}